Janssen Biotech Offers up to $1Bn to Irish Biotech for a Bowel Inflammation Drug

Janssen Biotech and Theravance Biopharma will develop together a drug to treat bowel inflammation diseases like ulcerative colitis and Crohn&8217;s disease. Janssen BiotechÂhas set its eyes on a drug candidate being developed by the Irish Theravance Bi...